About Remepy
Remepy is a Healthcare company based in United States founded in 2022 by Michal Tsur. Healthcare software applications are developed and provided for medical use. Remepy has raised $51 million across 3 funding rounds from investors including TechAviv, NFX and Vine Ventures. Remepy offers products and services including Hybrid Drugs and Therapeutic App. Its focus areas include Services for Healthcare Providers, IT Outsourcing and Application Development. Its legal entity is Remepy, Inc. Its competitors include Significo and Medplum; 2 of its 2 listed competitors have raised funding.
Company details
Remepy was established in 2022 in the United States as a provider of healthcare software application services. Operations are centered on delivering software solutions tailored to healthcare needs, including application development and support. The company is led by co-founder Michal Tsur. Services encompass various digital tools for healthcare providers, with a focus on efficiency in medical workflows. Geographic presence is maintained within the U.S. market.
- Headquarters United States
- Founders Michal Tsur
- SectorsHealthcare
- Website remepy.com
- Social LinkedIn
- Legal Name Remepy, Inc.
- Total Equity Funding$51M (USD)
in 3 rounds
- Latest Funding Round$36M (USD), Series A
Aug 2026
- InvestorsTechAviv
& 13 more
Products & Services of Remepy
Remepy offers a comprehensive portfolio of products and services, including Hybrid Drugs and Therapeutic App.
Drugs integrated with software to enhance effectiveness for various diseases.
App providing tailored interventions to support drug treatments.
Funding Insights of Remepy
Remepy has successfully raised a total of $51M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $36 million completed in August 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $51M
- Total Rounds 3
- Last Round Series A — $36M
- First Round $5M
(Jun 2023)
- Investors Count 14
All 3 funding rounds of Remepy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2026 | $36M | Series A | – | O.G. Venture Partners | |
| May 2024 | $10M | Seed | – | NFX | |
| Jun 2023 | $5M | Seed | – | TechAviv |
14 investors in total: 14 institutional.
Investors in Remepy
Remepy has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include TechAviv, NFX and Vine Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm offering funding and tools for startups in technology and investment sectors. | nfx.com | |||
Venture capital investments are directed toward early-stage technology companies. | vineventures.com | New York, United States | ||
PsyMed Ventures is focused on funding mental health innovations. | 2022 | psymed.ventures | ||
Firstime Ventures is focused on investing in sustainable technology companies. | firstime.vc | |||
Early-stage tech investments are made by Supernode Ventures. | 2017 | supernode.vc | New York, United States | |
A pre-seed fund is operated for ambitious Israeli founders. | fresh.fund | Israel | ||
| 97212.vc | ||||
Venture capital fund investing in early-stage tech startups | samsungnext.com | Berlin, Germany | ||
A venture fund focused on women-led high-growth companies is operated. | stagenext.vc | |||
| og-vp.com |
Investor details for Remepy
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Remepy
4 people are tracked at Remepy (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Michal Tsur | Co-Founder | Leadership |
Ran Buck | President And CBO - Chief Business Officer | Leadership |
Or Shoval | Co-CEO | Leadership |
Dorit Sokolov | Business Development & Strategy | Team |
Complete people profiles for Remepy
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Remepy
3 dated milestones of Remepy across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Remepy is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series A, of $36.0M.
Competitors of Remepy
Remepy has 2 listed competitors in our database, 2 of them funded. They include Significo and Medplum.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| significo.com | 2014 | Austin, United States | $12M | Software development services are provided by Significo in Austin. | ||
| medplum.com | 2021 | San Francisco, United States | $125,000 | Healthcare application development services are provided by Medplum. |
Detailed competitors of Remepy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Remepy
The website of Remepy (remepy.com) receives about 4.6K visits a month.
- Monthly visits4.6K
▲ 101.2% vs previous month
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as Remepy (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Remepy
Complete news archive for Remepy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Remepy
Remepy was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Remepy is headquartered in United States.
Remepy is a funded company, having raised a total of $51M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Jun 2023.
Remepy was established in 2022 in the United States as a provider of healthcare software application services. Operations are centered on delivering software solutions tailored to healthcare needs, including application development and support. The company is led by co-founder Michal Tsur. Services encompass various digital tools for healthcare providers, with a focus on efficiency in medical workflows. Geographic presence is maintained within the U.S. market.
Remepy offers Hybrid Drugs and Therapeutic App.
Remepy has 14 investors. Key investors include TechAviv, NFX, Vine Ventures, PsyMed Ventures, and Firstime Ventures.
Remepy operates through Remepy, Inc..